Offering conducted by agent Aegis Capital at $0.17 per ordinary share
By Devika Patel
Knoxville, Tenn., April 12 - Rosetta Genomics Ltd. said it plans a $1.38 million registered direct offering of stock that will be conducted through Aegis Capital Corp.
The company will sell 8.1 million ordinary shares at $0.17 apiece. The price per share is a 52.78% discount to the April 11 closing share price of $0.36.
Settlement is expected April 17.
Proceeds will be used for operations and other general corporate purposes.
Based in Rehovot, Israel, Rosetta Genomics develops and provides microRNA-based molecular diagnostics.
| Issuer: | Rosetta Genomics Ltd.
|
| Issue: | Ordinary shares
|
| Amount: | $1,377,000
|
| Shares: | 8.1 million
|
| Price: | $0.17
|
| Warrants: | No
|
| Agent: | Aegis Capital Corp.
|
| Pricing date: | April 12
|
| Settlement date: | April 17
|
| Stock symbol: | Nasdaq: ROSG
|
| Stock price: | $0.36 at close April 11
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
